Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-15 · accession 0001567619-21-020653 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-17 | 2021-11-15 | ATRA | Newell Joe | Chief Ops Off | M - OptEx | $12.15 | +3,500 | 123.4K | +3% | +$42.5K |
| D | 2021-11-17 | 2021-11-15 | ATRA | Newell Joe | Chief Ops Off | S - Sale+OE | $17.71 | -7,000 | 116.4K | -6% | -$124.0K |
| DM | 2021-11-17 | 2021-11-15 | ATRA | Newell Joe | Chief Ops Off | M - OptEx | $0.00 | -3,500 | 9,917 | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | M | A | 3,500 | $12.15 | 123,429 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-15 | S | D | 7,000 | $17.71 | 116,429 | D | — | — | (F2) The price in Column 4 is a weighted average sale price. The prices actually received ranged from $17.62 to $17.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-15 | M | D | 2,792 | $0.00 | 32,083 | D | $12.15 · — to 2030-02-28 | 2,792 Common Stock | (F3) 1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-15 | M | D | 708 | $0.00 | 9,917 | D | $12.15 · — to 2030-02-28 | 708 Common Stock | (F3) 1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service. |